Recent Developments and Future Directions with HER-2 in Breast Cancer and Other Tumor Types. Proceedings of a roundtable. August 11-14, 1999. Olympic Valley, California, USA.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D015870:Gene Expression; D018734:Genes, erbB-2; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics; D018719:Erb-b2 Receptor Tyrosine Kinases
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases